Jordan B, Mitchell C, Anderson A, Farkas N, Batrla R. The clinical and health economic value of clinical laboratory diagnostics. Ejifcc. 2015;26(1):47–62.
Bossuyt PMM, Reitsma JB, Linnet K, Moons KGM. Beyond diagnostic accuracy: the clinical utility of diagnostic tests. Clin Chem. 2012;58(12):1636–43.
Dugum M, McCullough AJ. Diagnosis and management of alcoholic liver disease. J Clin Transl Hepatol. 2015;3:109–16.
Sidhu MS, Dellsperger KC. Cardiovascular problems in dialysis patients: impact on survival. Adv Perit Dial. 2010;26:47–52.
Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 2012;60(14):1207–16. https://doi.org/10.1016/j.jacc.2012.03.074.
Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice. Diabetes Metab Res Rev. 2000;16:164–71.
Christodoulides N, Floriano PN, Sanchez X, et al. Programmable Bio-NanoChip Technology for the Diagnosis of Cardiovascular Disease at the Point of Care. Method DeBakey Cardiovasc J. 2012;8(1):6–12.
Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A, et al. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. Aids. 2008;22:115–22.
Price D, Freeman D, Cleland J, Kaplan A, Cerasoli F. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J. 2011;20(1):15–22. https://doi.org/10.4104/pcrj.2010.00060.
Schols AMR, Dinant GJ, Hopstaken R, Price CP, Kusters R, Cals JWL. International definition of a point-of-care test in family practice: a modified e-Delphi procedure. Fam Pract. 2018;35(4):475–80.
Cals J, Van Weert H. Point-of-care tests in general practice: hope or hype? Eur J Gen Pract. 2013;19(4):251–6.
Sohn AJ, Hickner JM, Alem F. Use of point-of-care tests (POCTs) by US primary care physicians. J Am Board Fam Med. 2016;29(3):371–6. https://doi.org/10.3122/jabfm.2016.03.150249.
Kankaanpää M, Raitakari M, Muukkonen L, Gustafsson S, Heitto M, Palomäki A, et al. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department. Scand J Trauma Resusc Emerg Med. 2016;24(125):1–7.
Kozel TR, Burnham-Marusich AR. Point-of-care testing for infectious diseases: past, present, and future Thomas. J Clin Microbiol. 2017;55(8):2313–20.
Laurence CO, Gialamas A, Bubner T, Yelland L, Willson K, Ryan P, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60(572):166–71.
Lingervelder D, Koffijberg H, Kusters R, Ijzerman MJ. Point-of-care testing in primary care: a systematic review on implementation aspects addressed in test evaluations. Int J Clin Pract. 2019;73(10):1–12.
Korte BJ, Rompalo A, Manabe YC, Gaydos CA. Overcoming challenges with the adoption of point-of-care testing. Point Care J Near-Patient Test Technol. 2020;19(3):77–83.
Hobbs FDR, Delaney B, Fitzmaurice DA, Wilson S, Hyde CJ, Thorpe GH, et al. A review of near patient testing in primary care. Health Technol Assess (Rockv). 1997;1(5):1–229.
Nichols JH, Christenson RH, Clarke W, Gronowski A, Hammett-Stabler CA, Jacobs E, et al. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: Evidence-based practice for point-of-care testing. Clin Chim Acta. 2007;379(1–2):14–28.
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition). J Chin Integr Med. 2009;7(9):889–96.
St John A, Price CP. Economic evidence and point-of-care testing. Clin Biochem Rev. 2013;34(2):61–74.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D. Consolidated Health Economic Evaluation Reporting Standards (CHEERS ) statement. BMC Med. 2013;11(80)
Owusu-Edusei K, Gift TL, Ballard RC. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in Sub-Saharan Africa. Sex Transm Dis. 2011;38(11):997–1003.
Hunter R. Cost-effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England. Adv Ther. 2015;32(1):69–85.
Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess (Rockv). 2015;19(58):1–228.
Spaeth B, Shephard M, Kokcinar R, Duckworth L, Omond R. Impact of point-of-care testing for white blood cell count on triage of patients with infection in the remote Northern Territory of Australia. Pathology. 2019;51(5):512–7.
Henson G, Ghonim E, Swiatlo A, King S, Moore K, King S, et al. Cost-benefit and effectiveness analysis of rapid testing for MRSA carriage in a hospital setting. Clin Lab Sci J. 2014;27(1):13–20.
Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH. Feasibility, cost-effectiveness and patients’ acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol. 2008;87(11):905–10.
Coyle D, Buxton MJ, Brien BJO. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12:421–7.
Wurcel V, Cicchetti A, Garrison L, Kip MMA, Koffijberg H, Kolbe A, et al. The value of diagnostic information in personalised healthcare: a comprehensive concept to facilitate bringing this technology into healthcare systems. Public Health Genom. 2019;22:8–15.
Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health. 2013;16(6 SUPPL.):S20–6. https://doi.org/10.1016/j.jval.2013.06.008.
Haga SB. Challenges of development and implementation of point of care pharmacogenetic testing. Expert Rev Mol Diagn. 2016;16(9):949–60.
Huckle D. The impact of new trends in POCTs for companion diagnostics, non-invasive testing and molecular diagnostics. Expert Rev Mol Diagn. 2015;15(6):815–27.
Benjamin Crocker J, Lee-Lewandrowski E, Lewandrowski N, Baron J, Gregory K, Lewandrowski K. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014;142(5):640–6.
Grieve R, Beech R, Vincent J, Mazurkiewicz J. Near patient testing in diabetes clinics: Appraising the costs and outcomes. Health Technol Assess (Rockv). 1999;3(15).
Kip MMA, Ijzerman MJ, Henriksson M, Merlin T, Weinstein MC, Phelps CE, et al. Toward alignment in the reporting of economic evaluations of diagnostic tests and biomarkers: the AGREEDT checklist. Med Decis Mak. 2018;38(7):778–88.
Price CP, St John A. The value proposition for point-of-care testing in healthcare: HbA1c for monitoring in diabetes management as an exemplar. Scand J Clin Lab Invest. 2019;79(5):298–304. https://doi.org/10.1080/00365513.2019.1614211.
Breheny K, Sutton AJ, Deeks JJ. Model-based economic evaluations of diagnostic point of care tests were rarely fit for purpose. J Clin Epidemiol. 2019;109:1–11. https://doi.org/10.1016/j.jclinepi.2018.11.003.
Howick J, Cals JWL, Jones C, Price CP, Pluddemann A, Heneghan C, et al. Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open. 2014;4(8):e005611.
Frank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S, et al. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019;3018(18):1–9.
Goldstein LN, Wells M, Vincent-Lambert C. The cost of time: a randomised, controlled trial to assess the economic impact of upfront, point-of-care blood tests in the Emergency Centre. African J Emerg Med. 2019;9(2):57–63. https://doi.org/10.1016/j.afjem.2019.01.011.
Gout-Zwart JJ, Olde Hengel EHJ, Hoogland P, Postma MJ. Budget impact analysis of a renal point-of-care test in Dutch community pharmacies to prevent antibiotic-related hospitalizations. Appl Health Econ Health Policy. 2019;17(1):55–63. https://doi.org/10.1007/s40258-018-0426-2.
Lee DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, Mayer KH, Tripathy S, et al. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: cost-effectiveness analysis for India’s public sector. PLoS ONE. 2019;14(7):1–17.
Pooran A, Theron G, Zijenah L, Chanda D, Clowes P, Mwenge L, et al. Point of care Xpert MTB / RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation. Lancet Glob Health. 2019;7(6):e798-807. https://doi.org/10.1016/S2214-109X(19)30164-0.
Rahamat-Langendoen J, Melchers WJG, Van Der WGJ. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study. J Med Virol. 2019;91(January):1408–14.
Rajasingham R, Pollock NR, Linas BP. The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons. Open Forum Infect Dis. 2017;4(4).
Esteve M, Rosinach M, Llordés M, Calpe J, Montserrat G, Pujals M, et al. Case-finding in primary care for coeliac disease: accuracy and cost-effectiveness of a rapid point-of-care test. United Eur Gastroenterol J. 2018;6(6):855–65.
Holmes EAF, Harris SD, Hughes A, Craine N, Hughes DA. Cost-effectiveness analysis of the use of point-of-care C-reactive protein testing to reduce antibiotic prescribing in primary care. Antibiotics. 2018;7(4):106.
Lubell Y, Do NTT, Nguyen KV, Ta NTD, Tran NTH, Than HM, et al. C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting—a cost benefit analysis. Antimicrob Resist Infect Control. 2018;7:1–6.
Spaeth BA, Kaambwa B, Shephard MDS, Omond R. Economic evaluation of point-of-care testing in the remote primary health care setting of Australia’s Northern Territory. Clin Outcomes Res. 2018;10:269–77.
El-Osta A, Woringer M, Pizzo E, Verhoef T, Dickie C, Ni MZ, et al. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis. BMJ Open. 2017;7(8):e015494.
Hyle EP, Rosettie KL, Osher B, Maggiore P, Parker RA, Peter T, et al. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. Aids. 2017;31(15):2135–45.
Kip MMA, Koffijberg H, Moesker MJ, Ijzerman MJ, Kusters R. The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care. BMC Cardiovasc Disord. 2017;17:1–9.
Lewandrowski E, Yeh S, Baron J, Crocker JB, Lewandrowski K. Implementation of point-of-care testing in a general internal medicine practice : A con fi rmation study. Clin Chim Acta. 2017;473(August):71–4.
You JHS, Tam LP, Lee NLS. Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting. PLoS ONE. 2017;12(7):1–11.
Heffernan A, Barber E, Thomas R, Fraser C, Pickles M, Cori A. Impact and cost-effectiveness of point-of-care CD4 testing on the HIV epidemic in South Africa. PLoS ONE. 2016;11(7):1–12.
Janković SM, Kostić M. Cost-effectiveness of introducing point-of-care test for detection of level of glycogen phosphorylase in early diagnostic algorithm of acute coronary syndrome. Value Heal Reg Issues. 2016;10:79–84.
Ward MJ, Self WH, Singer A, Lazar D, Pines JM. Cost-effectiveness analysis of early point-of-care lactate testing in the emergency department. J Crit Care. 2016;36:69–75. https://doi.org/10.1016/j.jcrc.2016.06.031.
Whitney RE, Santucci K, Hsiao A, Chen L. Cost-effectiveness of point-of-care testing for dehydration in the pediatric ED. Am J Emerg Med. 2016;34(8):1573–5. https://doi.org/10.1016/j.ajem.2016.05.075
Challen L, Agbahiwe S, Cantieri T, Olivetti JG, Mbah T, Mendoza-becerra Y, et al. Impact of point-of-care implementation in pharmacist-run anticoagulation clinics within a community-owned health system: a two-year retrospective analysis. Hosp Pharm. 2015;50(9):783–8.
Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, et al. Point-of-Care CD4 testing to inform selection of antiretroviral medications in South African antenatal clinics : a cost- effectiveness analysis. PLoS ONE. 2015:1–19. https://doi.org/10.1371/journal.pone.0117751
Hendriksen JM, Geersing GJ, Van Voorthuizen SC, Oudega R, Ten Cate-Hoek AJ, Joore MA, et al. The cost-effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care. Expert Rev Mol Diagn. 2015;15(1):125–36.
Asha SE, Fat Chan AC, Walter E, Kelly PJ, Morton RL, Ajami A, et al. Impact from point of care devices on emergency department patient processing times compared to central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emerg Med J. 2014;31(9):714–9.
Crocker BJ, Lee-Lewandrowski E, Lewandrowski N, Baron J, Gregory K, Lewandrowski K. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014;142(5):640–6.
Chadee A, Blackhouse G, Goeree R. Point-of-care hemoglobin A1ctesting: a budget impact analysis. Ont Health Technol Assess Ser. 2014;14(9):1–23.
Resch S, Lehe J, Su AE, Jani IV, Peter T, Quevedo J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014;11(9):e1001725.
Nilsson S, Andersson A, Janzon M, Karlsson J, Levin L, Nilsson S, et al. Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting cost consequences of point-of-care troponin T testing in a Swedish primary health care setting. Scand J Prim Health Care. 2014;32(4):241–7.
Turner KME, Round J, Horner P, Macleod J, Goldenberg S, Deol A, et al. An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sex Transm Infect. 2014;90:104–11.
Huang W, Gaydos CA, Barnes MR, Jett-Goheen M, Blake DR. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Infect. 2013;89(2):108–14.
Oppong R, Jit M, Smith RD, Butler CC, Melbye H, Mölstad S, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract. 2013;63(612):465–71.
Van Dyck W, Vértes G, Palaniappan M, Gassull D, Jain P, Schulthess D, et al. Acute coronary syndrome: what is the cost-effectiveness of prevention, point-of-care technology and telemonitoring? Health Policy Technol. 2012;1(3):173–7.
Cals JWL, Ament AJHA, Hood K, Butler CC, Hopstaken RM, Wassink GF, et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract. 2011;17(6):1059–69. https://doi.org/10.1111/j.1365-2753.2010.01472.x.
Fitzgerald P, Goodacre S, Cross E, Dixon S. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) trial. Acad Emerg Med. 2011;18(5):488–95.
Owusu-Edusei K, Gift TL, Ballard RC. Cost-effectiveness of a dual test to prevent adverse pregnancy outcomes in Sub-Saharan Africa. Sex Transm Dis. 2011;38(11):997–1003.
Golden AB, Hill JA, O’Riordan MA, Sandhaus LM. Point-of-care blood gas analysis in the pediatric cardiac catheterization suite: a clinical outcome study. Point Care. 2010;9(2):108–10.
Laurence CO, Moss JR, Briggs NE, Beilby JJ. The cost-effectiveness of point of care testing in a general practice setting: Results from a randomised controlled trial. BMC Health Serv Res. 2010;10.
Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis. 2008;35(9):775–84.
Udeh B, Schneider J, Ohsfeldt R. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci. 2008;336(3):254–64.